Takara Bio Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
120.42 M |
Public Float |
- |
Takara Bio Inc. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY30.37 |
Market Cap |
JPY267.32 B |
Shares Outstanding |
120.42 M |
Public Float |
46.05 M |
Address |
7-4-38 Nojihigashi Kusatsu Shiga 525 Japan |
Employees | - |
Website | http://www.takara-bio.co.jp |
Updated | 07/08/2019 |
Takara Bio, Inc. is engaged in the development and marketing of genetic engineering technologies. It operates through the following business segments: Genetic Engineering Research, AgriBio, and Gene Medicine. The Genetic Engineering Research segment offers research reagents, scientific instruments, and contract research services that are essential for biotechnology research. |